Publication Database

The publication database contains all articles from HZI staff (formerly Gesellschaft für Biotechnologische Forschung (GBF)) since 2000.

 

Lochner,M., Berard,M., Sawa,S., Hauer,S., Gaboriau-Routhiau,V., Fernandez,T.D., Snel,J., Bousso,P., ... , Cerf-Bensussan,N., Eberl,G. (2011)
Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells
Journal of Immunology 186 (3)
Zelinskyy,G., Dietze,K.K., Husecken,Y.P., Schimmer,S., Nair,S., Werner,T., Gibbert,K., Kershaw,O., Gruber,A.D., ... , Sparwasser,Tim*, Dittmer,U. (2009)
The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response
Blood 114 (15)
Pellegrini,M., Calzascia,T., Toe,J.G., Preston,S.P., Lin,A.E., Elford,A.R., Shahinian,A., Lang,P.A., Lang,K.S., Morre,M., Assouline,B., Lahl,K., Sparwasser,Tim*, Tedder,T.F., Paik,J.H., DePinho,R.A., Basta,S., ... , Ohashi,P.S., Mak,T.W. (2011)
IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology
Cell 144 (4)
Berod,L., Heinemann,C., Heink,S., Escher,A., Stadelmann,C., Drube,S., Wetzker,R., ... , Norgauer,J., Kamradt,T. (2011)
PI3Kgamma deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome
European Journal of Immunology 41 (3)
Hadis,U., Wahl,B., Schulz,O., Hardtke-Wolenski,M., Schippers,A., Wagner,N., Muller,W., Sparwasser,Tim*, ... , Forster,R., Pabst,O. (2011)
Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria
Immunity 34 (2)
Steinmann,E., Pietschmann,Thomas* (2010)
Hepatitis C virus P7 - a viroporin crucial for virus assembly and an emerging target for antiviral therapy
Viruses 285 (41)
Schussler-Lenz,M., Schneider,C.K. (2010)
[Clinical trials with advanced therapy medicinal products]
Bundesgesundheitsblatt.Gesundheitsforschung.Gesundheitsschutz 53 (1)
Goetz,K.B., Pfleiderer,M., Schneider,C.K. (2010)
First-in-human clinical trials with vaccines--what regulators want
Nature Biotechnology 28 (9)
Schneider,C.K., Salmikangas,P., Jilma,B., Flamion,B., Todorova,L.R., Paphitou,A., Haunerova,I., Maimets,T., Trouvin,J.H., Flory,E., Tsiftsoglou,A., Sarkadi,B., Gudmundsson,K., O'Donovan,M., Migliaccio,G., Ancans,J., Maciulaitis,R., Robert,J.L., Samuel,A., Ovelgonne,J.H., Hystad,M., Fal,A.M., Lima,B.S., Moraru,A.S., Turcani,P., Zorec,R., Ruiz,S., Akerblom,L., Narayanan,G., Kent,A., Bignami,F., Dickson,J.G., Niederwieser,D., Figuerola-Santos,M.A., Reischl,I.G., Beuneu,C., Georgiev,R., Vassiliou,M., Pychova,A., Clausen,M., Methuen,T., Lucas,S., Schussler-Lenz,M., Kokkas,V., Buzas,Z., MacAleenan,N., Galli,M.C., Line,A., Gulbinovic,J., Berchem,G., Fraczek,M., Menezes-Ferreira,M., Vilceanu,N., Hrubisko,M., Marinko,P., Timon,M., Cheng,W., Crosbie,G.A., Meade,N., di Paola,M.L., Vandendriessche,T., Ljungman,P., D'Apote,L., Oliver-Diaz,O., ... , Buttel,I., Celis,P. (2010)
Challenges with advanced therapy medicinal products and how to meet them
Nature Reviews Drug Discovery 9 (3)
Buttel,I.C., Voller,K., Schneider,C.K. (2010)
Immunogenicity and its impact on benefit/risk considerations in the authorisation of biopharmaceuticals
Current Drug Safety 5 (4)